Significant association of estrogen receptor binding site variation with bipolar disorder in females

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Graae, Lisette ^a   Karlsson, Robert ^a   Paddock, Silvia ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; BINDING SITE; BIPOLAR DISORDER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA BINDING; ESTROGEN BLOOD LEVEL; FEMALE; GENE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATHOGENESIS; RECEPTOR BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; TGM2 GENE; ADOLESCENT; AGED; GENETICS; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; BINDING SITES; BIPOLAR DISORDER; FEMALE; GENOTYPE; GTP-BINDING PROTEINS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; TRANSGLUTAMINASES; YOUNG ADULT;

EID: 84857545053     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032304     Document Type: Article

References (71)

1. Bijl RV, Ravelli A, van Zessen G, (1998) Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 33: 587-595.
2. Bijl RV, van Zessen G, Ravelli A, de Rijk C, Langendoen Y, (1998) The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design. Soc Psychiatry Psychiatr Epidemiol 33: 581-586.
3. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB, (1993) Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 29: 85-96.
4. Weissman MM, Klerman GL, (1977) Sex differences and the epidemiology of depression. Arch Gen Psychiatry 34: 98-111.
5. Weissman MM, Bland R, Joyce PR, Newman S, Wells JE, et al. (1993) Sex differences in rates of depression: cross-national perspectives. Journal of Affective Disorders 29: 77-84 doi:10.1016/0165-0327(93)90025-F.
6. Wilhelm K, Parker G, (1994) Sex differences in lifetime depression rates: fact or artefact? Psychol Med 24: 97-111.
7. Craddock N, Sklar P, (2009) Genetics of bipolar disorder: successful start to a long journey. Trends in Genetics 25: 99-105 doi:10.1016/j.tig.2008.12.002.
8. Diflorio A, Jones I, (2010) Is sex important? Gender differences in bipolar disorder. International Review of Psychiatry 22: 437-452 doi:10.3109/09540261.2010.514601.
9. Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, et al. (2009) Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 14: 755-763 doi:10.1038/mp.2009.43.
10. Leibenluft E, (1996) Women with bipolar illness: clinical and research issues. Am J Psychiatry 153: 163-173.
11. Freeman MP, Smith KW, Freeman SA, McElroy SL, Kmetz GE, et al. (2002) The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry 63: 284-287.
12. Payne JL, (2003) The role of estrogen in mood disorders in women. Int Rev Psychiatry 15: 280-290 doi:10.1080/0954026031000136893.
13. Grigoriadis S, Kennedy SH, (2002) Role of estrogen in the treatment of depression. Am J Ther 9: 503-509.
14. Halbreich U, Kahn LS, (2001) Role of estrogen in the aetiology and treatment of mood disorders. CNS Drugs 15: 797-817.
15. Mahon PB, Payne JL, MacKinnon DF, Mondimore FM, Goes FS, et al. (2009) Genome-Wide Linkage and Follow-Up Association Study of Postpartum Mood Symptoms. Am J Psychiatry 166: 1229-1237 doi:10.1176/appi.ajp.2009.09030417.
16. Viguera AC, Tondo L, Koukopoulos AE, Reginaldi D, Lepri B, et al. (2011) Episodes of Mood Disorders in 2,252 Pregnancies and Postpartum Periods. Am J Psychiatry Available:http://www.ncbi.nlm.nih.gov/pubmed/21799064. Accessed 1 August 2011.
17. Pae C-U, Mandelli L, Kim T-S, Han C, Masand PS, et al. (2009) Effectiveness of antidepressant treatments in pre-menopausal versus post-menopausal women: a pilot study on differential effects of sex hormones on antidepressant effects. Biomed Pharmacother 63: 228-235 doi:10.1016/j.biopha.2008.03.010.
18. Heldring N, Pike A, Andersson S, Matthews J, Cheng G, et al. (2007) Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87: 905-931 doi:10.1152/physrev.00026.2006.
19. van Nas A, GuhaThakurta D, Wang SS, Yehya N, Horvath S, et al. (2009) Elucidating the Role of Gonadal Hormones in Sexually Dimorphic Gene Coexpression Networks. Endocrinology 150: 1235-1249 doi:10.1210/en.2008-0563.
20. Driscoll MD, Sathya G, Muyan M, Klinge CM, Hilf R, et al. (1998) Sequence requirements for estrogen receptor binding to estrogen response elements. J Biol Chem 273: 29321-29330.
21. Klinge CM, (2001) Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29: 2905-2919.
22. Kulakosky P, McCarty M, Jernigan S, Risinger K, Klinge C, (2002) Response element sequence modulates estrogen receptor alpha and beta affinity and activity. Journal of Molecular Endocrinology 29: 137-152 doi:10.1677/jme.0.0290137.
23. Kealey C, Reynolds A, Mynett-Johnson L, Claffey E, McKeon P, (2001) No evidence to support an association between the oestrogen receptor beta gene and bipolar disorder. Psychiatr Genet 11: 223-226.
24. Middle F, Jones I, Robertson E, Morey J, Lendon C, et al. (2003) Variation in the coding sequence and flanking splice junctions of the estrogen receptor alpha (ERalpha) gene does not play an important role in genetic susceptibility to bipolar disorder or bipolar affective puerperal psychosis. Am J Med Genet B Neuropsychiatr Genet 118B: 72-75 doi:10.1002/ajmg.b.10021.
25. Weickert CS, Miranda-Angulo AL, Wong J, Perlman WR, Ward SE, et al. (2008) Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 17: 2293-2309 doi:10.1093/hmg/ddn130.
26. Ostlund H, Keller E, Hurd YL, (2003) Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann N Y Acad Sci 1007: 54-63.
27. Boomsma DI, Willemsen G, Sullivan PF, Heutink P, Meijer P, et al. (2008) Genome-wide association of major depression: description of samples for the GAIN Major Depressive Disorder Study: NTR and NESDA biobank projects. Eur J Hum Genet 16: 335-342 doi:10.1038/sj.ejhg.5201979.
28. Sullivan PF, de Geus EJC, Willemsen G, James MR, Smit JH, et al. (2008) Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry Available:http://www.ncbi.nlm.nih.gov/pubmed/19065144. Accessed 13 March 2009.
29. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, et al. (2006) Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38: 1289-1297 doi:10.1038/ng1901.
30. Lin C-Y, Vega VB, Thomsen JS, Zhang T, Kong SL, et al. (2007) Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet 3: e87 doi:10.1371/journal.pgen.0030087.
31. Zhao C, Gao H, Liu Y, Papoutsi Z, Jaffrey S, et al. (2010) Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1. Cancer Res 70: 5174-5183 doi:10.1158/0008-5472.CAN-09-4407.
32. Lesort M, Tucholski J, Miller ML, Johnson GV, (2000) Tissue transglutaminase: a possible role in neurodegenerative diseases. Prog Neurobiol 61: 439-463.
33. Assisi L, Autuori F, Botte V, Farrace MG, Piacentini M, (1999) Hormonal control of "tissue" transglutaminase induction during programmed cell death in frog liver. Exp Cell Res 247: 339-346 doi:10.1006/excr.1998.4358.
34. Campisi A, Bramanti V, Caccamo D, Li Volti G, Cannavò G, et al. (2008) Effect of growth factors and steroids on transglutaminase activity and expression in primary astroglial cell cultures. J Neurosci Res 86: 1297-1305 doi:10.1002/jnr.21579.
35. Fujita K, Kato T, Shibayama K, Imada H, Yamauchi M, et al. (2006) Protective effect against 17beta-estradiol on neuronal apoptosis in hippocampus tissue following transient ischemia/recirculation in mongolian gerbils via down-regulation of tissue transglutaminase activity. Neurochem Res 31: 1059-1068 doi:10.1007/s11064-006-9114-y.
36. Squassina A, Manchia M, Manconi F, Piccardi M, Ardau R, et al. (2008) A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample. Psychiatr Genet 18: 128-132 doi:10.1097/YPG.0b013e3282fb003d.
37. Cockcroft S, Carvou N, (2007) Biochemical and biological functions of class I phosphatidylinositol transfer proteins. Biochim Biophys Acta 1771: 677-691 doi:10.1016/j.bbalip.2007.03.009.
38. Shadan S, Holic R, Carvou N, Ee P, Li M, et al. (2008) Dynamics of lipid transfer by phosphatidylinositol transfer proteins in cells. Traffic 9: 1743-1756 doi:10.1111/j.1600-0854.2008.00794.x.
39. Kendler KS, Gatz M, Gardner CO, Pedersen NL, (2006) A Swedish national twin study of lifetime major depression. Am J Psychiatry 163: 109-114 doi:10.1176/appi.ajp.163.1.109.
40. Bradford M, Law MH, Stewart AD, Shaw DJ, Megson IL, et al. (2009) The TGM2 gene is associated with schizophrenia in a British population. Am J Med Genet B Neuropsychiatr Genet 150B: 335-340 doi:10.1002/ajmg.b.30813.
41. Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, et al. (2008) Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol 64: 332-343 doi:10.1002/ana.21450.
42. Fesus L, Piacentini M, (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27: 534-539.
43. Griffin M, Casadio R, Bergamini CM, (2002) Transglutaminases: nature's biological glues. Biochem J 368: 377-396 doi:10.1042/BJ20021234.
44. Ruan Q, Johnson GVW, (2007) Transglutaminase 2 in neurodegenerative disorders. Front Biosci 12: 891-904.
45. Samaroo D, Dickerson F, Kasarda DD, Green PHR, Briani C, et al. (2009) Novel immune response to gluten in individuals with schizophrenia. Schizophr Res Available:http://www.ncbi.nlm.nih.gov/pubmed/19748229. Accessed 21 September 2009.
46. Osterlund MK, Witt M-R, Gustafsson J-A, (2005) Estrogen action in mood and neurodegenerative disorders: estrogenic compounds with selective properties-the next generation of therapeutics. Endocrine 28: 235-242 doi:10.1385/ENDO:28:3:235.
47. Benes FM, Matzilevich D, Burke RE, Walsh J, (2006) The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry 11: 241-251 doi:10.1038/sj.mp.4001758.
48. Brietzke E, Stabellini R, Grassis-Oliveira R, Lafer B, (2011) Cytokines in Bipolar Disorder: Recent Findings, Deleterious Effects But Promise for Future Therapeutics. CNS Spectrums Available:http://www.ncbi.nlm.nih.gov/pubmed/21767467. Accessed 16 September 2011.
49. Gigante AD, Young LT, Yatham LN, Andreazza AC, Nery FG, et al. (2011) Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int J Neuropsychopharmacol 14: 1075-1089 doi:10.1017/S146114571000146X.
50. Herberth M, Koethe D, Levin Y, Schwarz E, Krzyszton ND, et al. (2011) Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival. Proteomics 11: 94-105 doi:10.1002/pmic.201000291.
51. Chiu C-T, Chuang D-M, (2011) Neuroprotective action of lithium in disorders of the central nervous system. Zhong Nan Da Xue Xue Bao Yi Xue Ban 36: 461-476 doi:10.3969/j.issn.1672-7347.2011.06.001.
52. Gupta A, Schulze TG, Nagarajan V, Akula N, Corona W, et al. (2011) Interaction networks of lithium and valproate molecular targets reveal a striking enrichment of apoptosis functional clusters and neurotrophin signaling. The Pharmacogenomics Journal Available:http://www.ncbi.nlm.nih.gov/pubmed/21383773. Accessed 16 September 2011.
53. Li Q, Li H, Roughton K, Wang X, Kroemer G, et al. (2010) Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia. Cell Death Dis 1: e56 doi:10.1038/cddis.2010.33.
54. Dubovsky SL, Murphy J, Thomas M, Rademacher J, (1992) Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am J Psychiatry 149: 118-120.
55. El Khoury A, Petterson U, Kallner G, Aberg-Wistedt A, Stain-Malmgren R, (2002) Calcium homeostasis in long-term lithium-treated women with bipolar affective disorder. Prog Neuropsychopharmacol Biol Psychiatry 26: 1063-1069.
56. Wasserman MJ, Corson TW, Sibony D, Cooke RG, Parikh SV, et al. (2004) Chronic lithium treatment attenuates intracellular calcium mobilization. Neuropsychopharmacology 29: 759-769 doi:10.1038/sj.npp.1300400.
57. Arevalo M-A, Santos-Galindo M, Bellini M-J, Azcoitia I, Garcia-Segura LM, (2010) Actions of estrogens on glial cells: Implications for neuroprotection. Biochim Biophys Acta 1800: 1106-1112 doi:10.1016/j.bbagen.2009.10.002.
58. Habauzit D, Flouriot G, Pakdel F, Saligaut C, (2011) Effects of estrogens and endocrine-disrupting chemicals on cell differentiation-survival-proliferation in brain: contributions of neuronal cell lines. J Toxicol Environ Health B Crit Rev 14: 300-327 doi:10.1080/10937404.2011.578554.
59. Tenenbaum M, Azab AN, Kaplanski J, (2007) Effects of estrogen against LPS-induced inflammation and toxicity in primary rat glial and neuronal cultures. J Endotoxin Res 13: 158-166 doi:10.1177/0968051907080428.
60. Vegeto E, Benedusi V, Maggi A, (2008) Estrogen anti-inflammatory activity in brain: A therapeutic opportunity for menopause and neurodegenerative diseases. Frontiers in Neuroendocrinology 29: 507-519 doi:16/j.yfrne.2008.04.001.
61. Park KC, Chung KC, Kim Y-S, Lee J, Joh TH, et al. (2004) Transglutaminase 2 induces nitric oxide synthesis in BV-2 microglia. Biochemical and Biophysical Research Communications 323: 1055-1062 doi:16/j.bbrc.2004.08.204.
62. Iga J-I, Ueno S-I, Yamauchi K, Numata S, Motoki I, et al. (2006) Gene expression and association analysis of LIM (PDLIM5) in major depression. Neurosci Lett 400: 203-207 doi:10.1016/j.neulet.2006.02.044.
63. Squassina A, Congiu D, Manconi F, Manchia M, Chillotti C, et al. (2008) The PDLIM5 gene and lithium prophylaxis: an association and gene expression analysis in Sardinian patients with bipolar disorder. Pharmacol Res 57: 369-373 doi:10.1016/j.phrs.2008.03.011.
64. Li X, Jope RS, (1995) Selective inhibition of the expression of signal transduction proteins by lithium in nerve growth factor-differentiated PC12 cells. J Neurochem 65: 2500-2508.
65. Amano K, Yamada K, Iwayama Y, Detera-Wadleigh SD, Hattori E, et al. (2008) Association study between the Down syndrome cell adhesion molecule (DSCAM) gene and bipolar disorder. Psychiatr Genet 18: 1-10 doi:10.1097/YPG.0b013e3281ac238e.
66. Yamakawa K, Huot YK, Haendelt MA, Hubert R, Chen XN, et al. (1998) DSCAM: a novel member of the immunoglobulin superfamily maps in a Down syndrome region and is involved in the development of the nervous system. Hum Mol Genet 7: 227-237.
67. McQuillin A, Rizig M, Gurling HMD, (2007) A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet Genomics 17: 605-617 doi:10.1097/FPC.0b013e328011b5b2.
68. Bauersachs S, Mitko K, Ulbrich SE, Blum H, Wolf E, (2008) Transcriptome studies of bovine endometrium reveal molecular profiles characteristic for specific stages of estrous cycle and early pregnancy. Exp Clin Endocrinol Diabetes 116: 371-384 doi:10.1055/s-2008-1076714.
69. Hucho TB, Dina OA, Kuhn J, Levine JD, (2006) Estrogen controls PKCepsilon-dependent mechanical hyperalgesia through direct action on nociceptive neurons. Eur J Neurosci 24: 527-534 doi:10.1111/j.1460-9568.2006.04913.x.
70. Kairouz R, Parmar J, Lyons RJ, Swarbrick A, Musgrove EA, et al. (2005) Hormonal regulation of the Grb14 signal modulator and its role in cell cycle progression of MCF-7 human breast cancer cells. J Cell Physiol 203: 85-93 doi:10.1002/jcp.20199.
71. Rusiñol AE, Bloj B, (1989) Estrogen treatment increases phospholipid transfer activities in chicken liver. J Biol Chem 264: 6612-6614.